IFP Advisors’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-760
Closed -$141K 3066
2020
Q1
$134K Buy
760
+39
+5% +$7.34K 0.01% 720
2019
Q4
$137K Sell
721
-234
-25% -$42.2K 0.01% 792
2019
Q3
$163K Buy
+955
New +$156K 0.01% 837
2019
Q1
$30K Sell
197
-2,098
-91% -$304K ﹤0.01% 1180
2018
Q4
$305K Sell
2,295
-120
-5% -$19.7K 0.02% 706
2018
Q3
$460K Sell
2,415
-460
-16% -$84.5K 0.02% 702
2018
Q2
$479K Sell
2,875
-1,370
-32% -$220K 0.02% 678
2018
Q1
$694K Hold
4,245
0.03% 506
2017
Q4
$694K Sell
4,245
-970
-19% -$174K 0.03% 506
2017
Q3
$1.07M Sell
5,215
-662
-11% -$154K 0.04% 427
2017
Q2
$1.43M Sell
5,877
-3,829
-39% -$900K 0.06% 331
2017
Q1
$2.32M Buy
9,706
+12
+0.1% +$2.79K 0.1% 219
2016
Q4
$2.04M Sell
9,694
-903
-9% -$187K 0.1% 223
2016
Q3
$2.44M Sell
10,597
-346
-3% -$84.5K 0.13% 176
2016
Q2
$2.53M Buy
10,943
+10,746
+5,455% +$2.48M 0.14% 154
2016
Q1
$30K Sell
197
-7,732
-98% -$2.21M ﹤0.01% 1179
2015
Q4
$2.48M Buy
+7,929
New +$2.36M 0.17% 130

Other funds holding AGN

IFP Advisors's AGN Position: Q2 2020 in Review

IFP Advisors sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 760 shares — an estimated $141K sold.

IFP Advisors first reported a position in AGN in Q4 2015 and held it in 17 quarters. The position peaked at $2.53M in Q2 2016. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • IFP Advisors reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • IFP Advisors sold 760 Allergan plc shares in Q2 2020, an estimated $141K.
  • IFP Advisors first reported a position in Allergan plc in Q4 2015 and held it in 17 quarters.
  • IFP Advisors's Allergan plc position peaked at $2.53M in Q2 2016.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on IFP Advisors's 13F filing for Q2 2020, filed 5 Aug 2020.